Posted Jul. 14, 2017 at 8:30 a.m.

Premium Lock Durham biotech's valley fever therapy is on FDA fast track

Published: 2017-07-14 08:30:00
Updated: 2017-07-14 08:30:00

Biotechnology  Image 1 of 3 · Next Image…

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders